Jason Aryeh is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 78,080 shares of LGND, which is worth approximately $8.25 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 1,252 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.1K
0% 3M change
9.16% 12M change
Total Value Held $8.25 Million

Jason Aryeh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Grant, award, or other acquisition
-
1,252 Added 1.58%
78,080 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
$125,833 $52.3 p/Share
2,406 Added 3.04%
76,828 Common Stock
Mar 05 2024
BUY
Exercise of conversion of derivative security
$113,839 $39.35 p/Share
2,893 Added 3.74%
74,422 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 1.57%
71,529 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
1,004 Added 1.42%
69,668 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
630 Added 0.91%
68,664 Common Stock

Also insider at

ANEB
Anebulo Pharmaceuticals, Inc. Healthcare
HSAQ
Health Sciences Acquisitions Corp 2 Financial Services
LNDC
LANDEC CORP \CA\ Healthcare
JA

Jason Aryeh

Director
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND